Quick Summary:
In the expanding landscape of the global Plasma Fractionation market, valuable insight and thorough understanding of industry trends are essential for any forward-thinking business executive. By acquiring our comprehensive market research report, you will be placing yourself in the driving seat for strategic decision-making, based on factual data and expert analysis.
Our report, honing in on the projected growth of this market to a considerable US$36.7 billion by 2030, provides meticulous breakdowns of sub-segments like Immunoglobulins and Albumin. With particular focus on the key geographical markets of the United States, China, Japan, Canada, and Germany, the study offers a deeper look at the competitive profiles and market shares of major industry participants. Our exclusive offering also provides a special coverage on various global trends, comprehensive analysis of market presence across multiple geographies, and a one-year complimentary update service, all designed to empower your strategic planning and strengthen your market positioning.
Global Plasma Fractionation Market to Reach $36.7 Billion by 2030
The global market for Plasma Fractionation estimated at US$24.1 Billion in the year 2022, is projected to reach a revised size of US$36.7 Billion by 2030, growing at a CAGR of 5.4% over the analysis period 2022-2030. Immunoglobulins, one of the segments analyzed in the report, is projected to record a 6.8% CAGR and reach US$13.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Albumin segment is readjusted to a revised 4.6% CAGR for the next 8-year period.
The U.S. Market is Estimated at $7 Billion, While China is Forecast to Grow at 5% CAGR
The Plasma Fractionation market in the U.S. is estimated at US$7 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$6.4 Billion by the year 2030 trailing a CAGR of 5% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.9% and 4.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4% CAGR.Select Competitors (Total 47 Featured) -
- Bio Products Laboratory Ltd.
- Biotest AG
- China Biologic Products, Inc.
- CSL Limited
- Green Cross Corporation
- Grifols SA
- Japan Blood Products Organization
- Kedrion SpA
- LFB SA
- Octapharma AG
- Sanquin
- Shanghai RAAS Blood Products Co., Ltd.
- Shire PLC
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
What is the estimated value of the Global Market for Plasma Fractionation?
What is the growth rate of the Global Market for Plasma Fractionation?
What is the forecasted size of the Global Market for Plasma Fractionation?
Who are the key companies in the Global Market for Plasma Fractionation?
| Report Attribute | Details |
|---|---|
| No. of Pages | 197 |
| Published | December 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 24.1 Billion |
| Forecasted Market Value ( USD | $ 36.7 Billion |
| Compound Annual Growth Rate | 5.4% |
| Regions Covered | Global |
Table of Contents
Companies Mentioned
A selection of companies mentioned in this report includes:
- Bio Products Laboratory Ltd.
- Biotest AG
- China Biologic Products, Inc.
- CSL Limited
- Green Cross Corporation
- Grifols SA
- Japan Blood Products Organization
- Kedrion SpA
- LFB SA
- Octapharma AG
- Sanquin
- Shanghai RAAS Blood Products Co., Ltd.
- Shire PLC
